Degradation Product in a Stored Aspirin Formulation
A community pharmacy receives a complaint that 300 mg aspirin tablets from a recently opened bottle smell strongly of vinegar and leave a gritty residue. The tablets were stored in a dispensing area near a window where summer temperatures reach 35 °C and relative humidity is about 70%. The label states a two-year expiry. A sample is sent to the quality-control laboratory, which reports a salicylic acid content of 1.8% w/w and visible surface erosion. The pharmacopoeial limit for salicylic acid in aspirin tablets is typically not more than 0.3% (or a specified limit in the relevant monograph).
1. Explain the chemistry of the observed change and why the storage conditions are responsible.
Read the worked answer
Aspirin (acetylsalicylic acid) is an ester of salicylic acid and acetic acid. Hydrolysis cleaves the acetyl group, yielding salicylic acid and acetic acid; the acetic acid produces the vinegar odour, and salicylic acid is the gritty, less soluble residue. The reaction is acid- and base-catalysed and is accelerated by heat and moisture, so storage at 35 °C and 70% RH near a window is exactly the condition that drives hydrolysis. Light can also promote related degradation. The measured 1.8% salicylic acid is six times the 0.3% limit, so the batch fails the monograph and must be removed from stock.
This is a real quality defect, not a cosmetic issue: degraded tablets have reduced potency, and salicylic acid is irritant to the gastric mucosa, increasing the risk of gastrointestinal adverse effects.
2. Recommend the corrective actions for the pharmacy and the counselling for patients who may have taken the affected tablets.
Read the worked answer
Actions: quarantine and return the entire batch to the supplier or destroy it according to local procedures and record the defect; check other stock for the same batch and for similar odour or grittiness; move aspirin and other moisture-sensitive products to a cool, dry, dark cupboard away from windows, ideally below 25 °C with humidity control; review storage monitoring records and staff training; and report the defect to the manufacturer and the national pharmacovigilance or medicines-quality authority.
Patient counselling: patients who took tablets from the affected bottle should be advised to stop using them and return them. Those who took only a few tablets are unlikely to come to harm, but anyone with stomach pain, nausea, black stools, ringing in the ears, or unusual bleeding should seek medical advice. Patients with asthma and aspirin sensitivity should be especially cautious. Replace the medicine with a fresh, correctly stored supply and reinforce that tablets should be kept in the original container with the desiccant and not stored in a bathroom or on a sunny windowsill.